22nd Century Cash Flow from Operating Activities 2011-2023 | XXII

22nd Century cash flow from operating activities from 2011 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
22nd Century Annual Cash Flow Ops
(Millions of US $)
2023 $-55
2022 $-52
2021 $-23
2020 $-16
2019 $-15
2018 $-18
2017 $-12
2016 $-10
2015 $-7
2014 $-7
2013 $4
2012 $-2
2011 $-3
2010 $-1
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.012B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $156.342B 16.41
Altria (MO) United States $78.753B 9.32
British American Tobacco (BTI) United Kingdom $69.915B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $21.801B 0.00
Universal (UVV) United States $1.316B 12.57
Turning Point Brands (TPB) United States $0.600B 11.91